Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115054
Chunk: 429

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 429
---
 determined by the Delaware Court of Chancery. However, appraisal rights are not available in all circumstances. Stockholders’ Derivative Actions Under the DGCL, any of our stockholders may bring an action in the Company’s name to procure a judgment in its favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of our capital stock at the time of the transaction to which the action relates. SPAC Warrants As of March 31, 2025, there are 6,958,309 SPAC Warrants outstanding, which are currently exercisable for an aggregate of up to 198,810 shares of Common Stock. The “SPAC Warrants” include (i) 5,555,354 Public Warrants and (ii) 1,402,955 Private Warrants. Public Warrants Each Public Warrant entitles the registered holder thereof to purchase one share of our Common Stock at a price of $402.50 per whole share, subject to adjustment as described in the Warrant Agreement. We may, in our sole discretion, lower the warrant exercise price at any time prior to the expiration date for a period of not less than 20 business days and any such reduction will be applied consistently to all of the warrants, provided that we will provide at least 20 days’ prior written notice to registered holders of the warrants. However, no Public Warrants will be exercisable for cash unless we have an effective and current registration statement covering the issuance of the Common Stock issuable upon exercise of the warrants and a current prospectus relating to such Common Stock. Notwithstanding the foregoing, if a registration statement covering the issuance of the Common Stock issuable upon exercise of the Public Warrants is not effective within 90 days from the consummation of the Business Combination, warrantholders may, from the 91st day after the consummation of the Business Combination until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis. The warrants will expire five years from the consummation of the Business Combination (i.e., November 10, 2027) at 5:00 p.m., New York City time or earlier upon redemption or liquidation. We may call the warrants for